Statement from Breast Cancer Care on research into the use of beta-blockers for breast cancer patients

Statement from Breast Cancer Care on research from the Queen’s Medical Centre, Nottingham, presented to the seventh European Breast Cancer Conference on the use of beta-blockers to help reduce metastasis and improve survival in breast cancer patients.

Rachel Rawson, Clinical Nurse Specialist at Breast Cancer Care, said:

“Our helpline regularly hears from women who are concerned about the risk of their breast cancer returning after treatment, so we know that this research will be of great interest to women, and men, diagnosed with breast cancer.

“While the small-scale study suggests that beta-blockers may reduce the risk of breast cancer returning, more research is needed in this area to determine the effectiveness and safety of the treatment before it can be routinely offered to breast cancer patients.

“It is important that people previously diagnosed with breast cancer are aware of any persistent or unexplained health symptoms either within the breast or the rest of the body. These should be reported to their medical team or GP for further assessment.”

ENDS

For further media information, please contact
Ian Manley
0207 960 3450/ 0770 290 1334
ian.manley@breastcancercare.org.uk